shutterstock_779236312_laborant
laborant / Shutterstock.com
13 February 2019Americas

Boehringer Ingelheim teams up with IBM to explore blockchain

The Canadian units of IBM and pharmaceutical company  Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Big Pharma
30 May 2019   German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.
Americas
17 June 2019   The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.

More on this story

Americas
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Big Pharma
30 May 2019   German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.
Americas
17 June 2019   The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.

More on this story

Americas
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Big Pharma
30 May 2019   German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.
Americas
17 June 2019   The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.